Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080466 | SCV000112368 | benign | not specified | 2018-05-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000205067 | SCV000261314 | likely benign | Duchenne muscular dystrophy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697072 | SCV000529134 | benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617990 | SCV000737149 | likely benign | Cardiovascular phenotype | 2016-08-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001831833 | SCV002092234 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-07-29 | no assertion criteria provided | clinical testing |